What adverse effects have been documented in case reports of patients treated with Ocrevus?

20 October 2026Original research1 min read

By Tripdatabase.

Abstract

Ocrevus treatment in patients with multiple sclerosis is associated with a wide range of adverse effects, as documented in case reports, including neutropenia, interstitial lung disease, and various immune-mediated responses. Clinicians should employ vigilant monitoring and management strategies to mitigate risks.

Keywords

Multiple Sclerosis Research Studies
ocrelizumab

Read around a topic while you study.

Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.

Discover Ward

multiple sclerosis

adverse drug reactions

neutropenia

interstitial lung disease

immune-related adverse events

drug safety

Open access

Authors

Tripdatabase

Source

Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.

doi.org/10.5281/zenodo.23509404

Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.

At a glance

Journal: Zenodo
Type: Original research
Published: 20 October 2026
Specialty: Neurology
Read time: 1 min
Authors: 1
DOI: 10.5281/zenodo.23509404